Stocks Health care OSCR
NYSE · Health careOscar Health, Inc. (OSCR)
Oscar Health, Inc. brought in $17.5B of revenue over the twelve months to September 30, 2026, up 54.8% from a year earlier. Net income was $855.5M, a net margin of 4.9%. Operating cash flow minus capital spending left $1.1B of free cash flow in fiscal 2025. At September 30, 2026 it held $4.5B in cash against $432.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Oscar Health, Inc.
- Net worth
- Oscar Health, Inc. has a market value (market cap) of $10.3B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $11.7B (+27.5% year on year), with a net loss of $443.2M. Over the 12 months to September 30, 2026: revenue $17.5B, net income $855.5M.
- Cash flow
- In fiscal 2025 operations brought in $1.1B of cash; after $36.4M of capital spending, free cash flow was $1.1B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Oscar Health, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Oscar Health, Inc. does
Oscar Health, Inc. is registered with the SEC under industry code SIC 6324 (Hospital & Medical Service Plans). Its shares trade on NYSE under the ticker OSCR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $11.7B | -$443.2M | -$1.69 | $1.1B |
| 2024 | $9.2B | $25.4M | $0.10 | $950.3M |
| 2023 | $5.9B | -$270.7M | -$1.22 | -$297.7M |
| 2022 | $4B | -$606.3M | -$2.85 | $351.3M |
| 2021 | $1.8B | -$572.6M | -$3.20 | -$207.6M |
| 2021 | $462.8M | -$406.8M | -$14.16 | $208.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where OSCR ranks in Health care
Latest SEC filings
What Oscar Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 72% to $5.1B versus the same quarter last year; diluted EPS $0.49 versus -$0.53.
- November 5, 2026
- September 18, 2026Activist stake changed SCHEDULE 13D/A
- September 16, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 70% to $4.9B versus the same quarter last year; diluted EPS $1.10 versus -$0.89.
- August 6, 2026
- June 9, 2026
- June 8, 2026
- June 2, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 53% to $4.6B versus the same quarter last year; diluted EPS $2.07 versus $0.92.
What is OSCR worth? A DCF from its reported cash flow
Insider trades
What the people running Oscar Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $26.8M worth of shares in the last 90 days and bought none on the open market. 12% of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 18, 2026 | Wittman Vanessa AmesDirector | Soldpre-planned (10b5-1) | 25,000 | $806K |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 6,268,097 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 75,520 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 1,323,589 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 4,855,810 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 164,218 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 1,323,589 | - |
| September 18, 2026 | Thrive Partners II GP, LLCDirector, 10% owner | Other changeindirect | 4,855,810 | - |
Who owns OSCR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Joshua Kushner13D, may seek influence with 15 related filers | 12.1% | September 18, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 402 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 20,587,428 | +3,277,889 |
| D. E. Shaw & Co., Inc. | 12,643,617 | +7,158,332 |
| Vanguard Portfolio Management LLC | 11,029,424 | +483,576 |
| Vanguard Capital Management LLC | 10,579,437 | -198,190 |
| American Century Companies Inc | 9,055,242 | +2,025,886 |
| Jane Street Group, LLC | 6,365,039 | +3,460,934 |
| Thrive Capital Management, LLC | 6,343,617 | 0 |
| Geode Capital Management, LLC | 5,819,186 | +786,931 |
| State Street Corp | 5,801,351 | +538,979 |
| Fmr LLC | 4,998,523 | +3,799,751 |
| Citadel Advisors LLC | 4,229,552 | +763,190 |
| Two Sigma Investments, LP | 4,035,689 | +1,686,164 |
| Dimensional Fund Advisors LP | 3,571,731 | -621,046 |
| BIT Capital GmbH | 3,417,957 | -2,903,464 |
| Renaissance Technologies LLC | 3,284,500 | new |
| Jacobs Levy Equity Management, Inc | 3,025,316 | +550,893 |
| Glynn Capital Management LLC | 2,575,828 | -15,964 |
| Assenagon Asset Management S.A. | 2,495,984 | +1,268,181 |
| Goldman Sachs Group Inc | 2,289,557 | +817,803 |
| Northern Trust Corp | 2,211,209 | +333,925 |
Insiders
11 insiders reported holding 10,412,235 shares in total, about $348.5M at the last price.
| Holder | Shares |
|---|---|
| Bertolini Mark TChief Executive Officer, Director | 7,751,570 |
| Blackley Richard ScottChief Financial Officer | 1,102,35856,250 held indirectly |
| Schlosser MarioDirector | 449,444 |
| Liang JanetPresident, Oscar Insurance | 248,697 |
| Baltrus VictoriaChief Accounting Officer | 213,631 |
| McAnaney AdamChief Legal Officer | 209,004 |
| Plouffe DavidDirector | 137,121 |
| Wittman Vanessa AmesDirector | 112,121 |
| Lang Laura WDirector | 82,840 |
| Gassen WilliamDirector | 82,840 |
Questions about OSCR
What does Oscar Health, Inc. do?
Oscar Health, Inc. is a company in the Health care sector, listed on NYSE as OSCR. Its shares trade on NYSE under the ticker OSCR.
What is Oscar Health, Inc.'s net worth?
Oscar Health, Inc. has a market value (market cap) of $10.3B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Oscar Health, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $855.5M on revenue of $17.5B, a net margin of 4.9%.
How much revenue does Oscar Health, Inc. make?
Over the twelve months to September 30, 2026 Oscar Health, Inc. reported revenue of $17.5B. That is 54.8% more than a year earlier.
When did Oscar Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Oscar Health, Inc.'s next earnings report?
Oscar Health, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare OSCR with
Follow OSCR
Get an email when Oscar Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Oscar Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.